Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) Equity Income: 2017-2020

Historic Equity Income for Arcus Biosciences (RCUS) over the last 4 years, with Dec 2020 value amounting to $613,000.

  • Arcus Biosciences' Equity Income was N/A to $1.2 million in Q4 2020 from the same period last year, while for Dec 2020 it was $256,000, marking a year-over-year change of. This contributed to the annual value of $613,000 for FY2020, which is 151.00% up from last year.
  • As of FY2020, Arcus Biosciences' Equity Income stood at $613,000, which was up 151.00% from -$1.2 million recorded in FY2019.
  • Over the past 5 years, Arcus Biosciences' Equity Income peaked at $613,000 during FY2020, and registered a low of -$1.2 million during FY2019.
  • Moreover, its 3-year median value for Equity Income was -$886,000 (2018), whereas its average is -$491,667.
  • Per our database at Business Quant, Arcus Biosciences' Equity Income plummeted by 112.98% in 2018 and then spiked by 151.00% in 2020.
  • Yearly analysis of 4 years shows Arcus Biosciences' Equity Income stood at -$416,000 in 2017, then slumped by 112.98% to -$886,000 in 2018, then tumbled by 35.67% to -$1.2 million in 2019, then skyrocketed by 151.00% to $613,000 in 2020.